Aurinia Pharmaceuticals
AUPH
#4596
Rank
S$2.70 B
Marketcap
S$20.51
Share price
2.65%
Change (1 day)
51.05%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2025 (TTM): S$0.10 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are S$0.26 Billion. In 2024 the company made an earning of S$15.86 Million, an increase over its 2023 earnings that were of -S$96.47 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$0.10 B590.45%
2024 S$15.86 M-116.44%
2023 -S$96.47 Million-31.8%
2022 -S$0.15 Billion-39.4%
2021 -S$0.24 Billion61.9%
2020 -S$0.15 Billion-9.73%
2019 -S$0.16 Billion92.65%
2018 -S$82.9 Million36.39%
2017 -S$60.78 Million106.29%
2016 -S$29.47 Million-15.4%
2015 -S$34.83 Million65.84%
2014 -S$21 Million129.82%
2013 -S$9.14 Million-26.6%
2012 -S$12.45 Million
2010 -S$7.05 Million-39.22%
2009 -S$11.6 Million-43.78%
2008 -S$20.63 Million-53.19%
2007 -S$44.07 Million42.97%
2006 -S$30.83 Million-23.03%
2005 -S$40.05 Million36.1%
2004 -S$29.43 Million172.57%
2003 -S$10.8 Million484.61%
2002 -S$1.85 Million
2000 -S$8.77 Million453.81%
1999 -S$1.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regeneron Pharmaceuticals
REGN
S$6.64 B 6,020.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-S$7.09 Million-106.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
-S$28.57 Million-126.31%๐Ÿ‡บ๐Ÿ‡ธ USA